Prevalence of MSA was high in non-CTD-ILD compared to studies with idiopathic IP, in which 6.6–24% of the subjects showed MSA including Jo-1, EJ, NXP-2, PL-7, TIF1-γ and SRP [11, 16, 26]. This evidence concerns the gene TRIM33 and interstitial lung disease.